| pubmed-article:15797521 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15797521 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:15797521 | lifeskim:mentions | umls-concept:C1368683 | lld:lifeskim |
| pubmed-article:15797521 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:15797521 | lifeskim:mentions | umls-concept:C0449851 | lld:lifeskim |
| pubmed-article:15797521 | lifeskim:mentions | umls-concept:C2003903 | lld:lifeskim |
| pubmed-article:15797521 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15797521 | pubmed:dateCreated | 2005-3-30 | lld:pubmed |
| pubmed-article:15797521 | pubmed:abstractText | The plasma peptide component (PPC) from ten melanoma (Mel), breast cancer (BC) and healthy individuals was examined by a combination of RP-HPLC, surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) and tandem mass spectrometry. A three peak pattern (2023, 2039, 2053.5 m/z) was primarily observed in melanoma. Two peaks (2236.1 and of 2356.3 m/z) were found only in BC samples. Fibrinogen alpha and inter-alpha-trypsin inhibitor heavy chain H4 fragments were absent in both tumor samples. | lld:pubmed |
| pubmed-article:15797521 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15797521 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15797521 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15797521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15797521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15797521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15797521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15797521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15797521 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15797521 | pubmed:month | May | lld:pubmed |
| pubmed-article:15797521 | pubmed:issn | 1570-0232 | lld:pubmed |
| pubmed-article:15797521 | pubmed:author | pubmed-author:GuardiolaJohn... | lld:pubmed |
| pubmed-article:15797521 | pubmed:author | pubmed-author:MartinBrian... | lld:pubmed |
| pubmed-article:15797521 | pubmed:author | pubmed-author:CaputoEmiliaE | lld:pubmed |
| pubmed-article:15797521 | pubmed:author | pubmed-author:PirozziGiusep... | lld:pubmed |
| pubmed-article:15797521 | pubmed:author | pubmed-author:LombardiMaria... | lld:pubmed |
| pubmed-article:15797521 | pubmed:author | pubmed-author:MoharramRamyR | lld:pubmed |
| pubmed-article:15797521 | pubmed:author | pubmed-author:TornatorePete... | lld:pubmed |
| pubmed-article:15797521 | pubmed:author | pubmed-author:LuongoVincenz... | lld:pubmed |
| pubmed-article:15797521 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15797521 | pubmed:day | 5 | lld:pubmed |
| pubmed-article:15797521 | pubmed:volume | 819 | lld:pubmed |
| pubmed-article:15797521 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15797521 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15797521 | pubmed:pagination | 59-66 | lld:pubmed |
| pubmed-article:15797521 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:meshHeading | pubmed-meshheading:15797521... | lld:pubmed |
| pubmed-article:15797521 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15797521 | pubmed:articleTitle | Peptide profiling in epithelial tumor plasma by the emerging proteomic techniques. | lld:pubmed |
| pubmed-article:15797521 | pubmed:affiliation | Institute of Genetics and Biophysics-I.G.B., A.Buzzati-Traverso, CNR, Via G. Marconi 10, I-80125 Naples, Italy. caputo@igb.cnr.it | lld:pubmed |
| pubmed-article:15797521 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15797521 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15797521 | lld:pubmed |
